| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Michael Faerm
Chief Financial Officer
|
59 | Not stated | Not stated | Not reported | |
|
Gerd Kochendoerfer
Chief Operating Officer
|
58 |
Since 2024
2 years
|
Not stated | $2,553,672 | |
|
Jonathan R. Haug
Also a director
President
|
Not stated | Not stated | Not stated | Not reported | |
|
Anne Johnson
Chief Accounting Officer
|
57 |
Since 2026
this year
|
Not stated | Not reported | |
|
Kevin Craig
Chief Medical Officer; Senior Vice President of Clinical Development
|
53 | Not stated | Not stated | Not reported | |
|
Glenn Short
Chief Scientific Officer
|
56 |
Since 2025
1 year
|
Not stated | Not reported | |
|
Christopher Anderson
Also a director
Secretary
|
Not stated | Not stated | Not stated | Not reported | |
|
Steffanie Lim-Ho
Treasurer
|
Not stated | Not stated | Not stated | Not reported | |
|
Jonathan Groff
Assistant Secretary
|
Not stated | Not stated | Not stated | Not reported | |
|
Jamie Burnett
Assistant Secretary
|
Not stated | Not stated | Not stated | Not reported | |
|
Katie Lodato
Assistant Treasurer
|
Not stated | Not stated | Not stated | Not reported | |
|
Srinivas Rao
Also a director
See remarks
Title from the Form 4 dated Sep 11, 2026
|
57 | Not stated | Not stated | $4,420,555 | |
|
Ryan Barrett
See remarks
Title from the Form 4 dated Sep 11, 2026
|
45 | Not stated | 2020 | $2,355,528 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 22, 2026 · updated by the 8-K of Sep 11, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Christian Angermayer
Board chair
|
47 |
2021
5 years
|
Not independent | None stated | None stated | $517,839 | |
|
Srinivas Rao, M.D., Ph.D.
CEO
|
57 |
2025
1 year
|
Not independent | None stated | None stated | Paid as CEO | |
|
Scott Braunstein, M.D.
|
62 |
2024
2 years
|
Not stated |
Audit
|
Caribou Biosciences, Inc. | $496,713 | |
|
Laurent Fischer, M.D.
|
62 |
2024
2 years
|
Not stated |
Compensation · Chair
|
Mirum Pharmaceuticals, Inc. | $237,949 | |
|
Robert Hershberg, M.D., Ph.D.
|
63 |
2025
1 year
|
Not stated |
Nominating
|
Adaptive Biotechnologies | $364,752 | |
|
John Hoffman
|
42 |
2025
1 year
|
Not stated |
Audit
Compensation
|
None stated | $396,103 | |
|
Andrea Heslin Smiley
|
58 |
2021
5 years
|
Not stated |
Nominating · Chair
|
Rockwell Medical, Inc. | $254,449 | |
|
Amir Kalali, M.D.
|
60 |
2021
5 years
|
Not stated |
Nominating
|
None stated | Not stated | |
|
Sabrina Martucci Johnson
|
59 |
2021
5 years
|
Not stated |
Audit · Chair
Compensation
|
None stated | $254,449 | |
|
Christopher Anderson
Joined Sep 11, 2026
|
- | - | - | - | - | - | |
|
Jonathan R. Haug
Joined Sep 11, 2026
|
- | - | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...